Teva Inks $769M Deal To Sell Allergan Assets In UK, Ireland
Teva Pharmaceutical Industries Ltd. said Wednesday that it has agreed to sell some of Allergan's assets in the U.K. and Ireland to Intas Pharmaceuticals Ltd. in a deal worth £603 million...To view the full article, register now.
Already a subscriber? Click here to view full article